NeoGenomics Stock Options
| NEO Stock | USD 17.69 0.71 4.18% |
NeoGenomics' latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.78. The NeoGenomics option chain provides detailed quote and price information for the current NeoGenomics option contracts. It shows all of NeoGenomics' listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on NeoGenomics
Analyzing NeoGenomics' in-the-money options over time can help investors to take a profitable long position in NeoGenomics regardless of its overall volatility. This is especially true when NeoGenomics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money NeoGenomics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with NeoGenomics' stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on NeoGenomics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if NeoGenomics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money NeoGenomics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if NeoGenomics Stock moves the wrong way.
NeoGenomics In The Money Call Balance
When NeoGenomics' strike price is surpassing the current stock price, the option contract against NeoGenomics stock is said to be in the money. When it comes to buying NeoGenomics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on NeoGenomics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
NeoGenomics Current Options Market Mood
NeoGenomics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps NeoGenomics Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most NeoGenomics' options investors are not very successful. NeoGenomics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current NeoGenomics contract
Base on the Rule 16, the options market is currently suggesting that NeoGenomics will have an average daily up or down price movement of about 0.0488% per day over the life of the 2025-01-17 option contract. With NeoGenomics trading at USD 17.69, that is roughly USD 0.008624. If you think that the market is fully incorporating NeoGenomics' daily price movement you should consider buying NeoGenomics options at the current volatility level of 0.78%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
NeoGenomics |
Purchasing NeoGenomics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" NeoGenomics calls. Remember, the seller must deliver NeoGenomics stock to the call owner when a call is exercised.
NeoGenomics Option Chain
When NeoGenomics' strike price is surpassing the current stock price, the option contract against NeoGenomics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
NeoGenomics' option chain is a display of a range of information that helps investors for ways to trade options on NeoGenomics. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for NeoGenomics. It also shows strike prices and maturity days for a NeoGenomics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | NEO250117C00008000 | 0 | 8.0 | 6.5 - 9.7 | 6.5 | In |
Call | NEO250117C00009000 | 0 | 9.0 | 5.7 - 8.9 | 5.7 | In |
Call | NEO250117C00010000 | 0 | 10.0 | 4.9 - 7.9 | 4.9 | In |
Call | NEO250117C00011000 | 0 | 11.0 | 4.0 - 7.0 | 4.0 | In |
Call | NEO250117C00012000 | 0 | 12.0 | 2.3 - 5.9 | 2.3 | In |
Call | NEO250117C00013000 | 0 | 13.0 | 1.85 - 5.1 | 1.85 | In |
Call | NEO250117C00014000 | 0 | 14.0 | 1.15 - 4.2 | 1.15 | In |
Call | NEO250117C00015000 | 0 | 15.0 | 1.35 - 1.65 | 1.35 | In |
Call | NEO250117C00016000 | 0 | 16.0 | 0.0 - 1.4 | 1.4 | |
Call | NEO250117C00017000 | 0 | 17.0 | 0.0 - 0.85 | 0.85 | |
Put | NEO250117P00008000 | 0 | 8.0 | 0.0 - 1.25 | 1.25 | |
Put | NEO250117P00009000 | 0 | 9.0 | 0.0 - 1.25 | 1.25 | |
Put | NEO250117P00010000 | 0 | 10.0 | 0.0 - 1.25 | 1.25 | |
Put | NEO250117P00011000 | 0 | 11.0 | 0.0 - 1.0 | 1.0 | |
Put | NEO250117P00012000 | 0 | 12.0 | 0.0 - 1.0 | 1.0 | |
Put | NEO250117P00013000 | 0 | 13.0 | 0.05 - 0.3 | 0.05 | |
Put | NEO250117P00014000 | 0 | 14.0 | 0.0 - 0.7 | 0.7 | |
Put | NEO250117P00015000 | 0 | 15.0 | 0.0 - 2.4 | 2.4 | |
Put | NEO250117P00016000 | 0 | 16.0 | 0.0 - 1.65 | 1.65 | In |
Put | NEO250117P00017000 | 0 | 17.0 | 0.0 - 2.85 | 2.85 | In |
NeoGenomics Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
NeoGenomics Market Cap Over Time
Market Cap |
| Timeline |
NeoGenomics Total Stockholder Equity
Total Stockholder Equity |
|
NeoGenomics Corporate Management
| Facmg MBA | Pres Officer | Profile | |
| George Cardoza | Pres Operations | Profile | |
| Gary Passman | Chief Officer | Profile | |
| Alicia Olivo | General Development | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeoGenomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeoGenomics. If investors know NeoGenomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeoGenomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.306 | Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth 0.104 | Return On Assets |
The market value of NeoGenomics is measured differently than its book value, which is the value of NeoGenomics that is recorded on the company's balance sheet. Investors also form their own opinion of NeoGenomics' value that differs from its market value or its book value, called intrinsic value, which is NeoGenomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeoGenomics' market value can be influenced by many factors that don't directly affect NeoGenomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeoGenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeoGenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeoGenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.